• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素治疗脑静脉窦血栓形成:有致命结局风险的患者。

Heparin treatment in cerebral sinus and venous thrombosis: patients at risk of fatal outcome.

作者信息

Mehraein S, Schmidtke K, Villringer A, Valdueza J M, Masuhr F

机构信息

Department of Neurology, Charité, Humboldt University, Berlin, Germany.

出版信息

Cerebrovasc Dis. 2003;15(1-2):17-21. doi: 10.1159/000067117.

DOI:10.1159/000067117
PMID:12499706
Abstract

We performed a retrospective analysis of 79 patients with cerebral sinus venous thrombosis, who were treated with a fixed regimen of dose-adjusted intravenous heparin, to determine predictors of a fatal course. The parameters investigated were the state of consciousness and the presence of intracranial haemorrhage (ICH) at the start of heparin treatment, involvement of the internal venous system, mean delay from initial symptom to stupor or coma and from initial symptom to hospital admission, focal neurological deficits, mean intracranial circulation time (ICT) on conventional angiography, and age and sex distribution. Mortality rate was 10% in this series (8/79). There was a strong link between the outcome and the level of vigilance: 53% of the patients with stupor or coma at the start of the heparin therapy died (8/15), whereas all of the 64 patients with no more than mildly impaired vigilance survived (p < 0.00001). Furthermore, mean age and mean ICT were significantly higher in the group of patients who died. There was a statistical trend (p = 0.056) for ICH to be more frequent in cases with fatal outcome, but there was reason to assume that ICH represented an epiphenomenon of a severe course rather than an independent predictor. Other investigated parameters were not linked with a fatal outcome.

摘要

我们对79例脑静脉窦血栓形成患者进行了回顾性分析,这些患者接受了剂量调整的静脉注射肝素固定方案治疗,以确定致命病程的预测因素。研究的参数包括肝素治疗开始时的意识状态和颅内出血(ICH)情况、颅内静脉系统受累情况、从初始症状到昏迷或昏睡以及从初始症状到入院的平均延迟时间、局灶性神经功能缺损、传统血管造影上的平均颅内循环时间(ICT)以及年龄和性别分布。该系列的死亡率为10%(8/79)。结局与警觉水平之间存在密切联系:肝素治疗开始时处于昏迷或昏睡状态的患者中有53%死亡(8/15),而64例警觉性仅有轻度受损的患者全部存活(p<0.00001)。此外,死亡患者组的平均年龄和平均ICT显著更高。致命结局的病例中ICH更常见有统计学趋势(p=0.056),但有理由认为ICH是严重病程的一种附带现象,而非独立的预测因素。其他研究参数与致命结局无关。

相似文献

1
Heparin treatment in cerebral sinus and venous thrombosis: patients at risk of fatal outcome.肝素治疗脑静脉窦血栓形成:有致命结局风险的患者。
Cerebrovasc Dis. 2003;15(1-2):17-21. doi: 10.1159/000067117.
2
Outcome of heparin-treated patients with acute cerebral venous sinus thrombosis: influence of the temporal pattern of intracerebral haemorrhage.肝素治疗急性脑静脉窦血栓形成患者的预后:脑内出血时间模式的影响
Eur J Neurol. 2016 Sep;23(9):1387-92. doi: 10.1111/ene.13064. Epub 2016 Jun 14.
3
Cerebral venous congestion as indication for thrombolytic treatment.脑静脉淤血作为溶栓治疗的指征。
Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):675-87. doi: 10.1007/s00270-007-9046-1.
4
Heparin in the treatment of cerebral venous thrombosis.肝素在脑静脉血栓形成治疗中的应用。
J Pak Med Assoc. 2006 Nov;56(11):541-3.
5
Cerebral venous and sinus thrombosis: patients with a fatal outcome during intravenous dose-adjusted heparin treatment.脑静脉和静脉窦血栓形成:静脉注射剂量调整肝素治疗期间出现致命结局的患者。
Neurocrit Care. 2004;1(3):355-61. doi: 10.1385/ncc:1:3:355.
6
Severe Cerebral Venous and Sinus Thrombosis: Clinical Course, Imaging Correlates, and Prognosis.重度脑静脉和静脉窦血栓形成:临床病程、影像学关联及预后
Neurocrit Care. 2016 Dec;25(3):392-399. doi: 10.1007/s12028-016-0256-8.
7
Isolated deep venous thrombosis--case series, literature review and long term follow up.孤立性深静脉血栓形成——病例系列、文献综述及长期随访
J Pak Med Assoc. 2006 Nov;56(11):557-9.
8
Intracranial venous hemodynamics is a factor related to a favorable outcome in cerebral venous thrombosis.颅内静脉血流动力学是与脑静脉血栓形成良好预后相关的一个因素。
Stroke. 2002 Jun;33(6):1645-50. doi: 10.1161/01.str.0000016507.94646.e6.
9
[Current controversies in the diagnosis and management of cerebral venous and dural sinus thrombosis].[脑静脉和硬脑膜窦血栓形成的诊断与治疗中的当前争议]
Nervenarzt. 2003 Aug;74(8):639-53. doi: 10.1007/s00115-003-1526-1.
10
Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage.脑静脉血栓形成和脑出血患者预后的预测因素
Stroke. 2007 Feb;38(2):337-42. doi: 10.1161/01.STR.0000254579.16319.35. Epub 2007 Jan 4.

引用本文的文献

1
Hemorrhagic stroke in children.儿童出血性中风
J Cent Nerv Syst Dis. 2024 Nov 1;16:11795735241289913. doi: 10.1177/11795735241289913. eCollection 2024.
2
Cerebral Vein Thrombosis and Direct Oral Anticoagulants: A Review.脑静脉血栓形成与直接口服抗凝剂:综述
J Clin Med. 2024 Aug 12;13(16):4730. doi: 10.3390/jcm13164730.
3
Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination.来自 FACME 特设专家工作组关于管理与 COVID-19 疫苗接种相关的脑静脉窦血栓形成的诊断和治疗建议。
Neurologia (Engl Ed). 2021 Jul-Aug;36(6):451-461. doi: 10.1016/j.nrleng.2021.05.001. Epub 2021 May 29.
4
[Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination].[FACME新冠疫苗接种相关脑静脉窦血栓形成管理临时专家工作组的诊断和治疗建议]
Neurologia. 2021 Jul-Aug;36(6):451-461. doi: 10.1016/j.nrl.2021.05.001. Epub 2021 May 6.
5
Local Intrasinus Thrombolysis for Cerebral Venous Sinus Thrombosis.局部窦内溶栓治疗脑静脉窦血栓形成
J Vasc Interv Neurol. 2016 Oct;9(2):49-54.
6
Cerebral Venous Sinus Thrombosis : Endovascular Treatment with Rheolysis and Aspiration thrombectomy.脑静脉窦血栓形成:采用溶栓和抽吸血栓切除术的血管内治疗
Clin Neuroradiol. 2017 Jun;27(2):235-240. doi: 10.1007/s00062-016-0540-1. Epub 2016 Sep 12.
7
Clinical Characteristics of Cerebral Venous Sinus Thrombosis in Patients with Systemic Lupus Erythematosus: A Single-Centre Experience in China.系统性红斑狼疮患者脑静脉窦血栓形成的临床特征:中国单中心经验
J Immunol Res. 2015;2015:540738. doi: 10.1155/2015/540738. Epub 2015 May 19.
8
Endovascular treatments for cerebral venous sinus thrombosis.脑静脉窦血栓形成的血管内治疗
J Thromb Thrombolysis. 2015 Oct;40(3):353-62. doi: 10.1007/s11239-015-1205-7.
9
Purification and characterization of novel fibrinolytic proteases as potential antithrombotic agents from earthworm Perionyx excavatus.从蚯蚓 Perionyx excavatus 中提取新型纤溶蛋白酶的纯化和特性分析及其作为潜在抗血栓药物的研究
AMB Express. 2011 Sep 30;1(1):26. doi: 10.1186/2191-0855-1-26.
10
Measurement of cerebral circulation times using dynamic whole-brain CT-angiography: feasibility and initial experience.使用动态全脑 CT 血管造影测量脑循环时间:可行性和初步经验。
Neurol Sci. 2012 Aug;33(4):741-7. doi: 10.1007/s10072-011-0785-z. Epub 2011 Sep 22.